Product Information
AMPHETAMINE SULFATE 5 MG TAB is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.4573 per EA under NDC 70010004001. Its NADAC has been published 116 times since Oct 18, 2023.
FDA first approved this application on Aug 5, 2019. Its Orange Book therapeutic-equivalence code is AA.
Strength
5 mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010004001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA212619FDA Approved
8/5/2019
TE Code
AA
On Market Since
8/15/2019
Pharmacological Classes
Price Statistics
The NADAC for AMPHETAMINE SULFATE 5 MG TAB has been published 116 times since Oct 18, 2023, and over the history we have for it it has declined 24.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4573 per EA |
|---|---|
| All-time high | $0.6272 (Dec 11, 2024) |
| All-time low | $0.3370 (Apr 22, 2026) |
| 52-week high | $0.5828 |
| 52-week low | $0.3370 |
| Median price | $0.5299 |
| Average price | $0.4882 |
| Largest weekly change | +62.9% (Nov 20, 2024) |
| Weeks tracked | 116 |
| Tracking since | Oct 18, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Granules Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amphetamine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMPHETAMINE SULFATE 5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for AMPHETAMINE SULFATE 5 MG TAB, manufactured by Granules Pharmaceuticals Inc., is $0.4573 per EA (NDC 70010004001), effective Sep 30, 2026.
How has the price of AMPHETAMINE SULFATE 5 MG TAB changed over time?
Over the history we have for it, the NADAC for AMPHETAMINE SULFATE 5 MG TAB has declined 24.4%. It has been tracked across 116 weekly CMS publications since Oct 18, 2023.
What are the highest and lowest recorded NADAC prices for AMPHETAMINE SULFATE 5 MG TAB?
Since Oct 18, 2023, the NADAC for AMPHETAMINE SULFATE 5 MG TAB has ranged from a low of $0.3370 (Apr 22, 2026) to a high of $0.6272 (Dec 11, 2024), with a median of $0.5299 per EA.
Are there cheaper alternatives to AMPHETAMINE SULFATE 5 MG TAB?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMPHETAMINE SULFATE 5 MG TAB, is $0.4247 per EA — about 7% below AMPHETAMINE SULFATE 5 MG TAB.
Who manufactures AMPHETAMINE SULFATE 5 MG TAB?
AMPHETAMINE SULFATE 5 MG TAB (NDC 70010004001) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.